Self-Assembling HER2 Nanobody Liposomes: Smarter Cancer Drug Delivery
This invention introduces a one-step self-assembly method that integrates HER2-targeted chimeric nanobodies directly into liposomal membranes, enabling scalable production of immunoliposomes with high drug encapsulation, improved tumor targeting, and reduced manufacturing complexity.
Background:
HER2-targeted therapies have shown promise for treating...
Published: 9/26/2025
|
Inventor(s): Yuan Wan, Mofizur Rahman
Keywords(s): Technologies
Category(s): Campus > Binghamton University
|